# Guerlain – FDA Inspection, Apr 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/guerlain/02c68a05-3673-404e-8646-005e23f80957
Source feed: FDA_Inspections

> FDA inspection 1237962 of Guerlain, April 26, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237962
- Company Name: Guerlain
- Inspection Date: 2024-04-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 948465 - 2015-09-25](https://www.keypedia.com/records/fda_inspections/guerlain/3fa960f4-6f4f-4c7e-930f-fbbe012a4ff7)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jacob-g-lutz/ca2710c6-064f-4728-9129-aad73e74f12d)

Company: https://www.keypedia.com/companies/guerlain/dcf1bbc3-d82d-4f2a-a548-ff5e3a38edaf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c